YPR153W Antibody

What is YPR153W and why is it studied in research?

YPR153W is an uncharacterized protein found in Saccharomyces cerevisiae (baker's yeast) with a molecular weight of approximately 15,778 Da. It is a membrane protein that likely contains multiple transmembrane domains and belongs to the TMEM170 family of proteins. This protein is of interest in basic research because it allows scientists to study fundamental aspects of membrane protein biology in a model organism. The protein is encoded on chromosome XVI (NC_001148.4) at position 833689..834245 . As a relatively uncharacterized protein, studying YPR153W contributes to our understanding of the yeast proteome and membrane protein function in eukaryotic cells, potentially revealing conserved mechanisms across species.

What are the key specifications of commercially available YPR153W antibodies?

YPR153W antibodies are typically produced as polyclonal antibodies in rabbits using recombinant Saccharomyces cerevisiae (strain 204508/S288c) YPR153W protein as the immunogen. These antibodies are generally available as IgG isotype and are supplied in liquid form, often preserved with agents such as Proclin 300 and formulated in glycerol/PBS buffer solutions. Commercial preparations are designed for research applications including Western blotting (WB) and enzyme-linked immunosorbent assay (ELISA) . It's important to note that, like many research antibodies, YPR153W antibodies should undergo proper validation to ensure specificity and reliability, especially given the concerns about antibody reproducibility highlighted by initiatives such as YCharOS .

How should YPR153W antibody be validated before use in critical experiments?

Proper validation of YPR153W antibody should follow a systematic approach that adheres to current best practices in antibody characterization. This process should include:

• Specificity testing: Utilize knockout (KO) yeast strains where the YPR153W gene has been deleted to confirm antibody specificity. The absence of signal in KO samples provides strong evidence for specificity.

• Cross-reactivity assessment: Test the antibody against lysates from related yeast species or strains to evaluate potential cross-reactivity with homologous proteins.

• Application-specific validation: Validate the antibody separately for each intended application (Western blot, ELISA, immunoprecipitation) as performance can vary between techniques.

• Concentration optimization: Determine the optimal working concentration through titration experiments to achieve the best signal-to-noise ratio.

• Reproducibility testing: Confirm results across multiple experiments and batches of the antibody.

This comprehensive validation approach aligns with the recommendations from antibody characterization initiatives like YCharOS, which emphasizes the use of KO cell lines and standardized protocols for antibody testing across multiple applications .

What are the optimal conditions for using YPR153W antibody in Western blot applications?

For optimal Western blot results with YPR153W antibody, researchers should follow these methodological guidelines:

• Sample preparation: Prepare yeast lysates using methods that effectively solubilize membrane proteins, such as glass bead disruption in the presence of detergents compatible with membrane protein extraction (e.g., 1% Triton X-100 or CHAPS).

• Gel selection: Use 12-15% SDS-PAGE gels to effectively resolve the target protein (~15.8 kDa).

• Transfer conditions: Employ semi-dry or wet transfer systems with methanol-containing transfer buffer to efficiently transfer the protein to PVDF or nitrocellulose membranes.

• Blocking: Block membranes with 5% non-fat dry milk or BSA in TBST for 1-2 hours at room temperature.

• Primary antibody incubation: Dilute YPR153W antibody (typically 1:500 to 1:2000, though optimization is recommended) in blocking buffer and incubate overnight at 4°C.

• Washing: Perform 4-5 washes with TBST, 5-10 minutes each.

• Secondary antibody: Use anti-rabbit HRP-conjugated secondary antibody at an appropriate dilution (typically 1:5000 to 1:10000).

• Detection: Visualize using enhanced chemiluminescence (ECL) substrate.

• Controls: Always include wild-type and YPR153W knockout yeast samples as positive and negative controls, respectively.

Careful adherence to these protocols will maximize specificity and sensitivity while minimizing background issues .

How can YPR153W antibody be used to study protein-protein interactions in yeast membrane systems?

YPR153W antibody can be effectively employed in several advanced techniques to investigate protein-protein interactions:

• Co-immunoprecipitation (Co-IP): Using YPR153W antibody for Co-IP can help identify binding partners of the YPR153W protein. The method requires:

  • Crosslinking of protein complexes in intact yeast cells using formaldehyde or DSP

  • Gentle lysis with appropriate detergents that maintain protein interactions

  • Immunoprecipitation with YPR153W antibody

  • Mass spectrometry analysis of co-precipitated proteins

• Proximity labeling: Combined with approaches like BioID or APEX2, YPR153W antibody can validate proximity labeling results by confirming the presence of labeled proteins.

• Immunofluorescence co-localization: Use of YPR153W antibody alongside antibodies against suspected interaction partners in immunofluorescence microscopy can provide spatial evidence for protein associations.

• FRET/BRET verification: After fluorescent or bioluminescent tagging of protein pairs, YPR153W antibody can be used to confirm proper expression and localization of the fusion proteins.

For all these approaches, proper controls are essential, including the use of knockout strains and non-specific antibodies of the same isotype to rule out false positives .

What strategies exist for troubleshooting non-specific binding of YPR153W antibody?

When encountering non-specific binding with YPR153W antibody, researchers can implement these evidence-based troubleshooting strategies:

• Stringent blocking optimization: Test different blocking agents (BSA, casein, commercial blockers) and concentrations to identify optimal conditions that reduce non-specific binding.

• Antibody titration: Perform detailed titration experiments to identify the minimum effective concentration that provides specific signal without background.

• Buffer modification: Adjust salt concentration (150-500 mM NaCl) and detergent levels (0.1-0.5% Tween-20 or Triton X-100) in washing and incubation buffers to disrupt non-specific interactions.

• Pre-adsorption: Pre-incubate the diluted antibody with knockout yeast lysate to remove antibodies that may bind to non-target proteins.

• Alternative epitope targeting: If possible, test antibodies raised against different epitopes of YPR153W to identify those with better specificity profiles.

• Signal validation: Always validate signals using knockout controls to distinguish between specific and non-specific binding patterns.

The systematic application of these approaches, combined with careful documentation of conditions and results, can significantly improve antibody specificity in experimental applications. This aligns with YCharOS recommendations for rigorous antibody characterization .

How should researchers design experiments to study YPR153W localization in yeast cells?

A comprehensive experimental design for studying YPR153W localization should include:

• Multiple visualization approaches:

  • Immunofluorescence using validated YPR153W antibody

  • Expression of fluorescent protein-tagged YPR153W (ensuring tag doesn't interfere with localization)

  • Subcellular fractionation followed by Western blotting with YPR153W antibody

• Co-localization markers:

  • Include established markers for yeast organelles (ER, Golgi, plasma membrane, etc.)

  • Use antibodies against known membrane protein compartment markers

• Dynamic localization studies:

  • Examine localization under different growth conditions

  • Monitor changes during cell cycle progression

  • Assess effects of cellular stressors on localization

• Genetic manipulations:

  • Analyze localization in strains with deletions of trafficking machinery components

  • Examine effects of point mutations in the YPR153W sequence on localization

• High-resolution approaches:

  • Consider super-resolution microscopy techniques for detailed localization

  • Electron microscopy with immunogold labeling for ultrastructural localization

• Controls:

  • YPR153W knockout strains as negative controls

  • Preabsorption controls for antibody specificity

  • Secondary antibody-only controls

This multi-faceted approach ensures robust localization data by leveraging complementary techniques and proper controls .

What are the key considerations when designing experiments to study post-translational modifications of YPR153W?

When investigating potential post-translational modifications (PTMs) of YPR153W, researchers should design experiments that address the following considerations:

• PTM prediction and targeting:

  • Use bioinformatic tools to predict potential PTM sites on YPR153W

  • Design experiments to target the most likely modifications (phosphorylation, glycosylation, ubiquitination, etc.)

• Modification-specific detection methods:

  • Phosphorylation: Phosphatase treatment, phospho-specific antibodies, Phos-tag gels

  • Glycosylation: Glycosidase treatment, lectin binding, migration shift assays

  • Ubiquitination: Ubiquitin-specific antibodies, tandem ubiquitin binding entities (TUBEs)

• Mass spectrometry approaches:

  • Immunoprecipitate YPR153W using validated antibody

  • Employ enrichment strategies specific to the PTM of interest

  • Use high-resolution MS/MS for precise PTM site mapping

• Genetic manipulation:

  • Generate mutants with altered potential modification sites

  • Delete or inhibit enzymes responsible for specific modifications

• Physiological relevance:

  • Examine how modifications change under different growth conditions

  • Investigate the functional consequences of modifications on protein localization, stability, or interactions

• Controls and validation:

  • Include samples from YPR153W knockout strains

  • Use both positive and negative controls for each modification-specific technique

  • Validate findings using complementary approaches

This systematic approach enables comprehensive characterization of YPR153W PTMs while minimizing false positives through rigorous controls .

How can researchers resolve contradictory results when using YPR153W antibody across different experimental platforms?

When faced with contradictory results using YPR153W antibody across different experimental platforms, researchers should implement this systematic resolution approach:

• Antibody validation assessment:

  • Re-validate the antibody specifically for each experimental platform

  • Compare results using different antibody lots or sources

  • Consider testing antibodies targeting different epitopes of YPR153W

• Technical differences analysis:

  • Document all technical differences between platforms (buffers, detergents, fixation methods)

  • Systematically test each variable to identify those influencing antibody performance

  • Standardize protocols across platforms where possible

• Sample preparation comparison:

  • Evaluate how different lysis or fixation methods affect the exposure of the target epitope

  • Test native versus denatured conditions to assess epitope accessibility

  • Consider membrane protein solubilization differences between methods

• Control expansion:

  • Include additional positive and negative controls

  • Use tagged versions of YPR153W alongside antibody detection

  • Implement spike-in controls to assess recovery and detection sensitivity

• Orthogonal approaches:

  • Employ antibody-independent methods to verify findings

  • Consider genetic approaches (e.g., CRISPR tagging) to confirm results

• Collaborative validation:

  • Have independent researchers replicate key experiments

  • Consider sending samples to specialized facilities for analysis

This structured approach helps identify sources of variability and determine which results are most reliable, aligning with reproducibility initiatives like YCharOS that emphasize standardized testing across multiple applications .

What statistical approaches are most appropriate for analyzing quantitative data generated using YPR153W antibody?

For robust statistical analysis of quantitative data generated using YPR153W antibody, researchers should consider these evidence-based approaches:

How might emerging antibody characterization technologies improve YPR153W antibody research?

Emerging technologies for antibody characterization could significantly advance YPR153W antibody research through several innovative approaches:

• High-throughput epitope mapping:

  • Peptide arrays and hydrogen-deuterium exchange mass spectrometry can precisely identify the epitopes recognized by YPR153W antibodies

  • This information can help predict potential cross-reactivity and optimize experimental conditions

• Single-cell antibody validation:

  • Single-cell immunofluorescence combined with transcriptomics can validate antibody specificity at unprecedented resolution

  • This approach would be particularly valuable for heterogeneous yeast populations

• Microfluidic antibody characterization platforms:

  • Automated, miniaturized systems can evaluate antibody binding kinetics, affinity, and specificity with minimal sample consumption

  • These platforms enable comprehensive characterization across multiple experimental conditions

• Computational antibody engineering:

  • Machine learning algorithms can predict antibody-antigen interactions and guide optimization

  • This could lead to improved YPR153W antibodies with enhanced specificity and sensitivity

• Multiplexed imaging technologies:

  • Techniques like imaging mass cytometry or CODEX can simultaneously visualize multiple proteins

  • These approaches could provide contextual information about YPR153W localization and interactions

• Open science antibody characterization initiatives:

  • Expansion of programs like YCharOS to include more yeast proteins would establish standardized validation protocols

  • This would address reproducibility concerns and provide reliable reference data for YPR153W antibodies

These emerging technologies align with the broader movement toward improved antibody characterization and could significantly enhance the reliability and utility of YPR153W antibodies in research.

What are the potential applications of YPR153W antibody in broader studies of membrane protein biology?

YPR153W antibody could serve as a valuable tool in advancing our understanding of fundamental membrane protein biology through these potential applications:

• Model system for membrane protein trafficking studies:

  • As a member of the TMEM170 family, YPR153W could serve as a model for studying evolutionary conserved mechanisms of membrane protein biogenesis

  • The antibody would allow tracking of trafficking pathways in wild-type and mutant backgrounds

• Membrane domain organization research:

  • YPR153W antibody could help elucidate principles of protein sorting and retention in specialized membrane microdomains

  • Combined with lipid analysis, this could reveal lipid-protein interactions governing membrane organization

• Stress response investigations:

  • Studying YPR153W localization and abundance under various cellular stresses could reveal membrane adaptation mechanisms

  • The antibody would enable quantitative analysis of protein redistribution during stress responses

• Evolutionary comparisons of membrane proteins:

  • YPR153W antibody could be tested for cross-reactivity with homologs in other fungal species

  • This could reveal evolutionary conservation and divergence in membrane protein structure and function

• Development of membrane protein research methodologies:

  • As a well-characterized system, YPR153W and its antibody could serve as controls in developing new membrane protein analysis techniques

  • This would contribute to method standardization across the membrane protein research field

• Integration with structural biology approaches:

  • YPR153W antibody could facilitate protein purification for structural studies

  • Antibody epitope mapping combined with structural data could provide insights into membrane protein topology

These applications demonstrate how a well-characterized YPR153W antibody could contribute to broader questions in membrane protein biology, extending beyond the specific protein to general principles of membrane organization and function .